Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Teveten 600mg tablets
0205052W0BBACAC
|
Teveten | Eprosartan | Cardiovascular System | 662 |
|
Aymes Shake Compact powder 57g sachets ginger
0913011F0BBACAA
|
Aymes powder 2.3 - 2.4 kcal/ml milkshake lower volume | Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 661 |
|
Ponstan 250mg capsules
1001010N0BBAAAA
|
Ponstan | Mefenamic acid | Musculoskeletal and Joint Diseases | 661 |
|
Crestor 40mg tablets
0212000AABBACAC
|
Crestor | Rosuvastatin calcium | Cardiovascular System | 660 |
|
Drainable night drainage bag 2 litre (2LNB)
22602406000
|
Drainable night drainage bag 2 litre (2LNB) | Night Drainage Bags | Incontinence Appliances | 660 |
|
Ethilon suture 2gauge 45cm length with 19mm curved reverse cutting P needle
20110000468
|
Ethilon suture 2gauge 45cm length with 19mm curved reverse cutting P needle | Surgical Sutures | Dressings | 660 |
|
Bonviva 150mg tablets
0606020W0BCAAAD
|
Bonviva | Ibandronic acid | Endocrine System | 659 |
|
Folysil all silicone catheter male 12Ch-22Ch
21020000861
|
Folysil all silicone catheter male 12Ch-22Ch | Catheters | Appliances | 659 |
|
Hypurin Porcine Isophane 100units/ml inj 10ml vials
0601012S0BCAEAB
|
Insulin isophane (CP Pharm) | Isophane insulin | Endocrine System | 659 |
|
Adanif XL 30mg tablets
0206020R0CIAAAN
|
Adanif | Nifedipine | Cardiovascular System | 658 |
|
Metyrol XL 30mg capsules
0404000M0BLACAV
|
Metyrol | Methylphenidate hydrochloride | Central Nervous System | 657 |
|
Spirit sterile leg bag 30cm long tube 750ml
22500505056
|
Spirit sterile leg bag 30cm long tube 750ml | Leg Bags | Incontinence Appliances | 657 |
|
Clear adhesive remover sachets
23153371502
|
Clear adhesive remover sachets | Adhesive Removers (Sprays/Liquids/Wipes) | Stoma Appliances | 656 |
|
Clear Advantage Spirit sheath style 3 wideband 32mm
22303953131
|
Clear Advantage Spirit sheath style 3 wideband 32mm | Incontinence Sheaths | Incontinence Appliances | 656 |
|
Nutrini Low Energy Multifibre liquid
0914021A0BBAAAA
|
Nutrini tube feed 0.75 kcal/ml with fibre | Tube feed 0.75 kcal/ml with fibre (0914021) | Nutrition and Blood | 656 |
|
Docusate sodium 0.5% ear drops
1201030F0AAABAB
|
Docusate sodium (Ear) | Docusate sodium | Ear, Nose and Oropharynx | 655 |
|
Liberty leg bag sleeve small
22800958001
|
Liberty leg bag sleeve small | Tubing And Accessories | Incontinence Appliances | 655 |
|
Moderma Flex urostomy bag 15-55mm transparnet
23960109725
|
Moderma Flex urostomy bag 15-55mm transparnet | Urostomy Bags | Stoma Appliances | 655 |
|
Phentolamine 2mg/0.35ml / Aviptadil 25microg/0.35ml inj amp
0704050ADAAAAAA
|
Phentolamine/aviptadil | Phentolamine/aviptadil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 655 |
|
Ko-Flex bandage 10cm x 6m
20020200857
|
Ko-Flex bandage 10cm x 6m | Arm Sling/Bandages | Dressings | 654 |
|
Noqdirna 50microgram oral lyophilisates
0605020E0BKAABU
|
Noqdirna | Desmopressin acetate | Endocrine System | 654 |
|
Chlorhexidine 0.2% oral spray sugar free
1203040E0AAAEAE
|
Chlorhexidine gluconate (Mouthwash) | Chlorhexidine gluconate | Ear, Nose and Oropharynx | 653 |
|
Fragmin 5,000units/0.2ml inj pre-filled syringes
0208010L0BBABAB
|
Fragmin | Dalteparin sodium | Cardiovascular System | 653 |
|
Juvela gluten free fibre bread rolls
0913271B0BEABAJ
|
Juvela specialist food replacer rolls/baguettes (G/F) | Specialist food replacer rolls/baguettes (0913271) | Nutrition and Blood | 653 |
|
Libra sterile leg bag long tube 1 litre
22502085007
|
Libra sterile leg bag long tube 1 litre | Leg Bags | Incontinence Appliances | 653 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.